Roche’s Kadcyla shows promise in early breast cancer
admin 16th October 2018 Uncategorised 0Roche has announced that its antibody drug conjugate Kadcyla cut the risk of disease recurrence when given after neoadjuvant treatment and surgery to certain breast cancer patients with residual disease.
More: Roche’s Kadcyla shows promise in early breast cancer
Source: News